Inventor · disambiguated record
Vishal Kamat
Also filed as: KAMAT VISHAL
4 granted patents·7 pending applications·18 citations·filing 2013–2025
71Inventor score
Files withREGENERON PHARMA11
Top patents by PatentIndex Score
11 records- 0193US10793624B2Human antibodies to Bet v 1 and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Oct 6, 2020·12 cites·18 claims
- 0292US11767358B2Human antibodies to Bet v 1 and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Sep 26, 2023·3 cites·40 claims
- 0382US9758592B2Recombinant cell surface capture proteinsREGENERON PHARMA·Filed 2013·Granted Sep 12, 2017·3 cites·8 claims
- 0476US2024083986A1Human antibodies to bet v 1 and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0569US12325752B2Immunoglobulin proteins that bind to NPR1 agonistsREGENERON PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·44 claims
- 0665US2025333524A1Immunoglobulin proteins that bind to npr1 agonistsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0757US2018118852A1Recombinant Cell Surface Capture ProteinsREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 0854US2014072979A1Isolating cells expressing secreted proteinsREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 0950US2017241887A1Isolating Cells Expressing Secreted ProteinsREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 1048US2025276092A1Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody responseREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1146US2014072980A1Isolating cells expressing secreted proteinsREGENERON PHARMA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vishal Kamat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →